ArticleThe Pan African medical journal2025
[A complex diagnostic triad mimicking macrophage activation syndrome: chronic lymphocytic leukemia and tuberculosis (a case report)].
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macrophage activation syndrome (MAS) is a rare and potentially fatal condition. Also known as macrophage activation syndrome, its diagnosis is based on the presence of at least five clinical and biological criteria. Bone marrow examination helps confirm the diagnosis by demonstrating the presence of numerous activated macrophages with multiple hemophagocytosis images. Through the case of an immunocompromised patient followed for chronic lymphocytic leukemia (CLL), we emphasize the difficulty of diagnosing MAS and the need to screen for underlying tuberculosis, which may be masked by manifestations of the lymphoproliferative syndrome. The diagnosis of MAS was established based on clinical, biological, and cytological abnormalities, with pleural tuberculosis identified as the triggering factor. This case emphasizes the need to consider opportunistic infections and to maintain a high index of suspicion in immunocompromised patients, illustrating an unusual clinical and epidemiological triad. Keywords: macrophage activation syndrome; chronic lymphocytic leukemia; pleural tuberculosis; diagnosis; treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.